Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
Micheal Avoseh, Doctoral Researcher at University of South Carolina Floyd School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in blood VTH, adding:
“I’m excited to share that our article, Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases, is now published in blood VTH.
This review explores how nanoparticle-based therapies may help address thrombo-inflammatory vascular disease, including approaches that target the endothelium—the inner lining of blood vessels—and approaches that do not.
It was a valuable opportunity to examine how drug delivery strategies could improve the way we approach complex vascular inflammation and thrombosis.
I’m grateful to my co-authors and mentors for their collaboration and guidance throughout this work.”
Title: Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases
Authors: Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia
-
Oct 9, 2026, 23:46Samuel Misiani Mbunya: Advancing Sickle Cell Care Through Collaboration at the 21st ASCAT Conference
-
Oct 9, 2026, 23:42Hadeel Swed: My First First-Author Publication in Thrombosis Research
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation